While the viruses play a major role in molecular and cell biology to epidemiology, immunobiology and medical research, it has now become more crucial due to the global pandemic effect.
The revelation of immunization has prompted the near eradication of several disease and has tremendously affected wellbeing and health.
Ongoing advances in vaccine innovation coming from the application of genetic engineering like mRNA & DNA are now providing an opportunity to target new diseases.
However, even with novel platforms, COVID-19 vaccine development poses challenges. Debate continues over the best methodology — for instance, targeting the full-length protein or just the receptor-binding domain.
This digital conference by MarketsandMarkets on Vaccines and Virology will bring together leading vaccine experts and virologists from around the world to share their recent research and progression made to rapidly develop a vaccine against COVID-19. The online forum will also hold discussions on novel concepts in virology and new generations of vaccines.
CEOs, CSOs, Directors, Heads, Managers, Group Leaders, Professors, Lecturers, Research Associates, Scientists, Investigators, Fellows, Readers from Pharmaceutical, Bio-pharmaceutical, Academics and Research Institutes working in-